Interactive Investor
>>

Chimeric Therapeutics Ltd Ordinary Shares (ASX:CHM) Share Price

CHM

Chimeric Therapeutics Ltd Ordinary Shares

APAC company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XASX

-

Updated: -

Loading...

Times are shown in GMT+11, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells.

ASX:CHM

AU0000121576

AUD

Loading...

Loading Comparison

Latest CHM News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News